You are using an outdated browser. Please upgrade your browser to improve your experience.
combined oxidative phosphorylation defect type 15
Disease Summary
Associated Targets (1)
Tbio
1
Mondo Description Combined oxidative phosphorylation defect type 15 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by onset in infancy or early childhood of muscular hypotonia, gait ataxia, mild bilateral pyramidal tract signs, developmental delay (affecting mostly speech and coordination) and subsequent intellectual disability. Short stature, obesity, microcephaly, strabismus, nystagmus, reduced visual acuity, lactic acidosis, and a brain neuropathology consistent with Leigh syndrome are also reported.
Uniprot Description An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem.
Mondo Term and Equivalent IDs
MONDO:0013987: combined oxidative phosphorylation defect type 15
Download Data for combined oxidative phosphorylation defect type 15
data still loading...
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
Description from UniProt.
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
DOID:0111491
OMIM:614947
Orphanet:319524
SCTID:763203009
UMLS:C3554182
MONDO:0013987
High level summary of knowledge for a disease, including descriptions and datasource references. Click the "?" for more details.